Sort by
Refine Your Search
-
Country
-
Field
-
, treatment of solid tumors, which represent 90% of all adult cancers, require additional T cell engineering. To solve this problem we are utilizing evolutionary biology to design potency enhancements that arm
-
based on outstanding scientific accomplishments as well as a research proposal that is aligned with the University’s research priorities. Following the KAUST strategy, innovation and the potential
-
study the cell cycle machinery and how it influences cancer biology in both cancer cells and stromal cells and leverage our discoveries to design new drug therapies for cancer. We have developed several
-
. This data may be transferred and disclosed to, and used by, HKU Innovation Holdings Limited and The University of Hong Kong for the above purposes. We are an equal opportunities employer and welcome